Why Iovance Biotherapeutics (IOVA) Effortlessly Soared 256% in Q3
Iovance Biotherapeutics (NASDAQ:IOVA) emerged as the top-performing mid-cap stock in the US market in the third quarter of the year, with shares soaring by 256 percent during the period, thanks to the...









